Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01IYQ
|
|||
| Former ID |
DIB009134
|
|||
| Drug Name |
TAK-201
|
|||
| Synonyms |
TAC-201; MT-201, Meiji
Click to Show/Hide
|
|||
| Indication | Allergy [ICD-11: 4A80-4A85; ICD-10: T78.4; ICD-9: 995.3] | Discontinued in Phase 2 | [1] | |
| Company |
Meiji Dairies Corp
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Immunoglobulin E (IgE) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031068) | |||
| REF 2 | Adecatumumab: an anti-EpCAM monoclonal antibody, from the bench to the bedside. Expert Opin Biol Ther. 2010 Jun;10(6):951-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.